LONDON–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/Research?src=hash” target=”_blank”gt;#Researchlt;/agt;–The global Lennox-Gastaut syndrome (LGS) treatment market is expected to
post a CAGR of close to 5% during the period 2019-2023, according to the
latest market research report by Technavio.
LGS is a rare, refractory, debilitating type of epilepsy with
life-threatening consequences in pediatric patients. The treatment for
LGS rely on the seizure type and requires a broad spectrum of
anti-epileptic drugs. The identification of LGS in the early stages
helps in treating it more effectively. As a result, many government and
non-government organizations are taking initiatives to increase the
awareness of the early diagnosis and treatment of LGS across the world.
For instance, the National Organization for Rare Disorders (NORD) and
Genetic and Rare Diseases (GARD) Information Center are raising
awareness about the signs and symptoms, causes, diagnosis, and standard
treatment of LGS in the US. Hence, the increase in the number of
organizations that create awareness about LGS will propel the growth of
the LGS treatment market during the forecast period.
As per Technavio, advances in surgical treatments will have a positive
impact on the market and contribute to its growth significantly over the
forecast period. This global
Lennox-Gastaut syndrome treatment market 2019-2023 research
report also analyzes other important trends and market drivers that will
affect market growth over 2019-2023.
Global Lennox-Gastaut syndrome treatment
market: Advances in surgical treatments
Corpus callosotomy is a palliative surgical procedure which has been
commonly used to treat patients with generalized seizures including drop
attacks due to LGS. However, callosotomy involves craniotomy with
microdissection. Hence, to overcome the downsides of corpus callosotomy,
many companies are introducing novel minimally invasive methods for
performing the surgical ablation of epileptogenic foci. For instance,
MR-guided laser interstitial thermal therapy (MRg-LITT) was introduced
recently, which can be used as a minimally invasive method for
performing the surgical ablation of epileptogenic foci and corpus
callosotomy. Such advances in surgical treatments will fuel the growth
of the global LGS treatment market during the forecast period.
“The number of patients with medical conditions such as trauma,
stroke, perinatal hypoxia, tuberous sclerosis, and cortical dysplasia is
increasing significantly. Congenital infections and infections to the
central nervous system, such as encephalitis and meningitis, are also
increasing which are major risk factors for LGS. This rise in the number
of patients with these risk factors is increasing the prevalence of LGS,
thereby driving the growth of the LGS treatment market” says a
senior research analyst at Technavio.
Global Lennox-Gastaut syndrome treatment
market: Segmentation analysis
This market research report segments the global Lennox-Gastaut syndrome
treatment market by type (surgical treatment and non-surgical treatment)
and geography (North America, Europe, Asia, and ROW).
The non-surgical treatment segment held the largest Lennox-Gastaut
syndrome treatment market share in 2018. The growth of the non-surgical
treatment segment can be attributed to the recent drug approvals for the
treatment of LGS and the adoption of a ketogenic diet.
The North America region led the market in 2018, followed by Europe,
Asia, and ROW respectively. North America dominated the global LGS
treatment market owing to the rising awareness of LGS and the increase
in funding for the research on LGS in this region. Also, the strategic
alliances among organizations that promote awareness about LGS are also
supporting the growth of the market in the region.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200